25.3 C
Accra
Friday, November 27, 2020
No menu items!

COVID-19 vaccine: Pfizer says it’s ‘94% effective in over 65 years old

Must Read

Weah bids farewell to ‘legend and icon’ Maradona

Liberia's President George Weah was among African football greats who have shared tributes to Argentina's football legend Diego Maradona,...

Cyber-crime suspects with 50,000 victims held in Nigeria

Three suspects alleged to have targeted government and private sector companies in more than 150 countries have been arrested...

Drake calls for Grammys to be replaced after The Weeknd is snubbed

Drake has called for the Grammys to be replaced with a new awards show, after several artists were overlooked...

The coronavirus vaccine developed by Pfizer and BioNTech appears to protect 94% of adults over 65 years old.

More data released from their ongoing phase three trial suggests it works equally well in people of all ages, races and ethnicities.

The companies say they will now apply for authorisation for emergency use of the jab in the US.

The findings are based on two doses given to more than 41,000 people around the world.

Last week, Pfizer and BioNTech published preliminary data showing the vaccine offered 90% protection against Covid-19 and there were no safety concerns.

This was followed by impressive data on another vaccine, made by US company Moderna, suggesting nearly 95% protection.

Today’s data from Pfizer and BioNTech suggests the vaccine is 95% effective based on 170 cases of Covid-19 developing in volunteers, with just eight in the group given the vaccine. The previous data was based on 94 cases.

The companies say there have been no serious safety concerns, but they did notice headaches and fatigue in around 2% of volunteers given the vaccine.

In the trial, 42% of all participants are from diverse ethnic backgrounds and 41% are aged between 56 and 85 years old.

The trial is still continuing and will collect data on the safety and efficacy of the vaccine for another two years.

The vaccine is being tested on people at 150 sites in the US, Germany, Turkey, South Africa, Brazil and Argentina.

The companies expect to produce up to 50 million doses of the vaccine this year and up to 1.3 billion doses by the end of 2021.

The UK has pre-ordered 40 million doses of this vaccine and should get 10 million by the end of the year.

SourceBBC NEWS

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest News

Weah bids farewell to ‘legend and icon’ Maradona

Liberia's President George Weah was among African football greats who have shared tributes to Argentina's football legend Diego Maradona,...

Cyber-crime suspects with 50,000 victims held in Nigeria

Three suspects alleged to have targeted government and private sector companies in more than 150 countries have been arrested in Nigeria's biggest city, Lagos,...

Drake calls for Grammys to be replaced after The Weeknd is snubbed

Drake has called for the Grammys to be replaced with a new awards show, after several artists were overlooked in this year's nominations. "I think...

Diego Maradona: Mourners to visit legend’s body as Argentina grieves

A million people are expected to pay their respects to the Argentine football legend Diego Maradona in the presidential palace in Buenos Aires. Three days...

Argentina declares three days of national mourning after Diego Maradona’s death at 60

Three days of national mourning have begun in Argentina following the death yesterday of football maestro Diego Maradona Maradona at the age of 60. His...

More Articles Like This